Background: Inflammatory bowel disease (IBD) is a chronic relapsing disease that requires evaluation using multiple objective tools. In Europe, bowel ultrasound (US) is a widely accepted modality used for the management of patients with IBD; however, its use in North America has only recently emerged as a potential technique. Objectives: Our goal was to identify current practice patterns of pediatric gastroenterologists and radiologists using bowel US in patients with IBD and highlight perceived limitations to the widespread adoption of this modality in North America. Methods: A 14-question survey was e-mailed to the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition internet bulletin board composed of 3,058 subscribers from 51 countries; the Society of Pediatric Radiology listserv composed of 1,917 subscribers worldwide; and the Society of Chairs of Radiology at Children’s Hospitals listserv. Descriptive summary statistics was used. Results: In North America, about one-quarter of gastroenterology and radiology participants reported using bowel US for IBD; over 3-fourths expressed an interest in using US more often. Bowel US was performed more frequently for Crohn’s disease. Both groups agreed the main limitation to using bowel US was concern for inter-observer variability and operator-dependent factors; radiologists reported that other modalities are more effective to assess IBD, whereas gastroenterologists reported unfamiliarity with bowel US indications and techniques. Conclusions: Our data show there is significant interest among both radiologists and gastroenterologists in using bowel US. However, lack of education, insufficient training, and perceived high inter-observer variability among US technologists are limitations preventing the widespread adoption of US for IBD in North America.

Keywords:
Bowel, Crohn’s disease, Pediatrics, Ultrasound, Utilization
1.
Braegger CP, Ballabeni P, Rogler D, Vavricka SR, Friedt M, Pittet V; Swiss IBD Cohort Study Group. Epidemiology of inflammatory bowel disease: is there a shift towards onset at a younger age?
J Pediatr Gastroenterol Nutr
. 2011 Aug;53(2):141–4.
2.
Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases.
Gastroenterology
. 2011 May;140(6):1785–94.
3.
Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.
Gastroenterology
. 2004 May;126(6):1504–17.
4.
Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. The costs of Crohn’s disease in the United States and other Western countries: a systematic review.
Curr Med Res Opin
. 2008 Feb;24(2):319–28.
5.
Mayo Clinic [Internet]. Mayo Clinic cost estimator [cited May 22, 2018]. Available from: https://costestimator.mayoclinic.org/.
6.
Desmond AN, McWilliams S, Maher MM, Shanahan F, Quigley EM. Radiation exposure from diagnostic imaging among patients with gastrointestinal disorders.
Clin Gastroenterol Hepatol
. 2012 Mar;10(3):259–65.
7.
Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology.
Br J Radiol
. 2008 May;81(965):362–78.
8.
Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies.
Radiology
. 2008 Apr;247(1):64–79.
9.
Dillman JR, Smith EA, Sanchez RJ, DiPietro MA, DeMatos-Maillard V, Strouse PJ, et al. Pediatric small bowel Crohn disease: correlation of US and MR enterography.
Radiographics
. 2015 May-Jun;35(3):835–48.
10.
Ahmad TM, Greer ML, Walters TD, Navarro OM. Bowel sonography and MR enterography in children.
AJR Am J Roentgenol
. 2016 Jan;206(1):173–81.
11.
Anupindi SA, Halverson M, Khwaja A, Jeckovic M, Wang X, Bellah RD. Common and uncommon applications of bowel ultrasound with pathologic correlation in children.
AJR Am J Roentgenol
. 2014 May;202(5):946–59.
12.
Rosenbaum DG, Conrad MA, Biko DM, Ruchelli ED, Kelsen JR, Anupindi SA. Ultrasound and MRI predictors of surgical bowel resection in pediatric Crohn disease.
Pediatr Radiol
. 2017 Jan;47(1):55–64.
13.
Dillman JR, Smith EA, Sanchez R, DiPietro MA, Dehkordy SF, Adler J, et al. Prospective cohort study of ultrasound-ultrasound and ultrasound-MR enterography agreement in the evaluation of pediatric small bowel Crohn disease.
Pediatr Radiol
. 2016 Apr;46(4):490–7.
14.
Barber JL, Maclachlan J, Planche K, Furman M, Crespi D, Bab N, et al. There is good agreement between MR enterography and bowel ultrasound with regards to disease location and activity in paediatric inflammatory bowel disease.
Clin Radiol
. 2017 Jul;72(7):590–7.
15.
Kucharzik T, Wittig BM, Helwig U, Börner N, Rössler A, Rath S, et al.; TRUST study group. Use of intestinal ultrasound to monitor Crohn’s disease activity.
Clin Gastroenterol Hepatol
. 2017 Apr;15(4):535–542.e2.
16.
Panés J, Bouzas R, Chaparro M, García-Sánchez V, Gisbert JP, Martínez de Guereñu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease.
Aliment Pharmacol Ther
. 2011 Jul;34(2):125–45.
17.
Neye H, Ensberg D, Rauh P, Peitz U, Mönkemüller K, Treiber G, et al. Impact of high-resolution transabdominal ultrasound in the diagnosis of complications of Crohn’s disease.
Scand J Gastroenterol
. 2010 Jun;45(6):690–5.
18.
Alison M, Kheniche A, Azoulay R, Roche S, Sebag G, Belarbi N. Ultrasonography of Crohn disease in children.
Pediatr Radiol
. 2007 Nov;37(11):1071–82.
19.
Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al.; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.
J Pediatr Gastroenterol Nutr
. 2014 Jun;58(6):795–806.
20.
Taylor SA, Mallett S, Bhatnagar G, Baldwin-Cleland R, Bloom S, Gupta A, et al.; METRIC study investigators. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial.
Lancet Gastroenterol Hepatol
. 2018 Aug;3(8):548–58.
21.
Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, et al. Role of US in detection of Crohn disease: meta-analysis.
Radiology
. 2005 Jul;236(1):95–101.
22.
Calabrese E, Maaser C, Zorzi F, Kannengiesser K, Hanauer SB, Bruining DH, et al. Bowel ultrasonography in the management of Crohn’s disease. A review with recommendations of an international panel of experts.
Inflamm Bowel Dis
. 2016 May;22(5):1168–83.
23.
Barber JL, Zambrano-Perez A, Olsen OE, Kiparissi F, Baycheva M, Knaflez D, et al. Detecting inflammation in inflammatory bowel disease - how does ultrasound compare to magnetic resonance enterography using standardised scoring systems?
Pediatr Radiol
. 2018 Jun;48(6):843–51.
24.
Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.
Proc Natl Acad Sci USA
. 2003 Nov;100(24):13761–6.
25.
Miles A, Bhatnagar G, Halligan S, Gupta A, Tolan D, Zealley I, et al.; METRIC investigators. Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn’s disease: patient acceptability and perceived burden.
Eur Radiol
. 2019 Mar;29(3):1083–93.
26.
Absah I, Bruining DH, Matsumoto JM, Weisbrod AJ, Fletcher JG, Fidler JL, et al. MR enterography in pediatric inflammatory bowel disease: retrospective assessment of patient tolerance, image quality, and initial performance estimates.
AJR Am J Roentgenol
. 2012 Sep;199(3):W367–75.
27.
Pallotta N, Civitelli F, Di Nardo G, Vincoli G, Aloi M, Viola F, et al. Small intestine contrast ultrasonography in pediatric Crohn’s disease.
J Pediatr
. 2013 Sep;163(3):778–84.e1.
28.
Novak K, Tanyingoh D, Petersen F, Kucharzik T, Panaccione R, Ghosh S, et al. Clinic-based point of care transabdominal ultrasound for monitoring Crohn’s disease: impact on clinical decision making.
J Crohn’s Colitis
. 2015 Sep;9(9):795–801.
29.
Griffey RT, Fowler KJ, Theilen A, Gutierrez A. Considerations in imaging among emergency department patients with inflammatory bowel disease.
Ann Emerg Med
. 2017 May;69(5):587–99.
30.
Stanley A, Wajanga BM, Jaka H, Purcell R, Byrne L, Williams F, et al. The impact of systematic point-of-care ultrasound on management of patients in a resource-limited setting.
Am J Trop Med Hyg
. 2017 Feb;96(2):488–92.
31.
Fraquelli M, Sarno A, Girelli C, Laudi C, Buscarini E, Villa C, et al. Reproducibility of bowel ultrasonography in the evaluation of Crohn’s disease.
Dig Liver Dis
. 2008 Nov;40(11):860–6.
32.
Jairath V, Ordas I, Zou G, Panes J, Stoker J, Taylor SA, et al. Reliability of measuring ileo-colonic disease activity in Crohn’s disease by magnetic resonance enterography.
Inflamm Bowel Dis
. 2018 Jan;24(2):440–9.
33.
Tielbeek JA, Makanyanga JC, Bipat S, Pendsé DA, Nio CY, Vos FM, et al. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI -scoring of severity, and correlation with Crohn disease endoscopic index of severity.
AJR Am J Roentgenol
. 2013 Dec;201(6):1220–8.
34.
Pew Research Center [Internet]. Response rates in telephone surveys have resumed their decline/ [cited August 15, 2019]. Available from: https://www.pewresearch.org/fact-tank/2019/02/27/response-rates-in-telephone-surveys-have-resumed-their-decline/.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.